Insider filing
Traded Jun 15 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Signed May 20, 2026 · Updated May 20, 2026
The Department of Defense placed a delivery order for $2.2K of Pfizer's CYKLOKAPRON on May 20, 2026. This is a routine purchase under an existing contract open to all bidders, part of $652K in similar awards over the past year.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
$2,246
Actual federal dollars obligated to date on this award
$2,246
A maximum, not earned revenue
$655K across 10 awards
Obligations to date on awards newly signed in the last 12 months, mapped to this company
82.9% from the largest awarding agency
Share of T12M mapped obligations
#10 of 10 mapped awards by obligations
Within the awards OQRO has ingested
Not available
No annual revenue figure from the company's SEC filings yet
exact identifier
Exact identifier > verified alias > manual override
Insider filing
Traded Jun 15 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Insider selling
Traded Jun 9 · filed 1 day laterNot reported under a pre-arranged trading plan
Pfizer's SVP & Controller sold $51K of Pfizer shares. The filing does not indicate a pre-arranged trading plan.
Insider filing
Traded May 29 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.